Familial risk of Endstage Renal Disease in a Caucasian population.

被引：0
|
作者：
ODea, DF [1 ]
Harnett, J [1 ]
Hefferton, D [1 ]
Parfrey, PS [1 ]
机构：
[1] MEM UNIV NEWFOUNDLAND, ST JOHNS, NF, CANADA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A1849 / A1849
页数：1
相关论文
共 50 条
  • [41] Assessment of knowledge in patients with endstage renal disease treated with hemodialysis
    Yeboah, MM
    Kleinman, JG
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : A62 - A62
  • [42] Burden of disease: Prevalence and incidence of endstage renal disease in Middle Eastern countries
    Shaheen, Faissal A. M.
    Al-Attar, Besher
    Ahmad, Mohammad Kamal
    Follero, Paul Mark
    CLINICAL NEPHROLOGY, 2020, 93 (07) : S120 - S123
  • [43] Secondary prevention using antioxidants of cardiovascular disease in endstage renal disease: SPACE
    Boat, M
    Smetana, S
    Weinstein, T
    Matas, Z
    Gafter, U
    Iaina, A
    Knecht, A
    Weissgarten, Y
    Fainaru, M
    Green, M
    EUROPEAN HEART JOURNAL, 2000, 21 : 458 - 458
  • [44] Disease Flare of Systemic Lupus Erythematosus in Patients With Endstage Renal Disease on Dialysis
    Kim, Young-Eun
    Choi, Su Jin
    Lim, Doo-Ho
    Kim, Hyosang
    Ahn, Soo Min
    Oh, Ji Seon
    Kim, Yong-Gil
    Lee, Chang-Keun
    Yoo, Bin
    Hong, Seokchan
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (10) : 1131 - 1137
  • [45] Clinical Implications of Belatacept Conversion in a High-Risk, Urban Renal Transplant Population.
    Valdepenas, B.
    Benken, J.
    Benedetti, E.
    Hajjiri, Z.
    Lichvar, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 687 - 688
  • [46] Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
    Ali Abbasi
    Eva Corpeleijn
    Ron T. Gansevoort
    Rijk O. B. Gans
    Joachim Struck
    Janin Schulte
    Hans L. Hillege
    Pim van der Harst
    Ronald P. Stolk
    Gerjan Navis
    Stephan J. L. Bakker
    Diabetologia, 2014, 57 : 1842 - 1849
  • [47] Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
    Abbasi, Ali
    Corpeleijn, Eva
    Gansevoort, Ron T.
    Gans, Rijk O. B.
    Struck, Joachim
    Schulte, Janin
    Hillege, Hans L.
    van der Harst, Pim
    Stolk, Ronald P.
    Navis, Gerjan
    Bakker, Stephan J. L.
    DIABETOLOGIA, 2014, 57 (09) : 1842 - 1849
  • [48] CONVERSION TO SIROLIMUS IN PEDIATRIC RENAL TRANSPLANT POPULATION.
    Azocar, M.
    Delucchi, A.
    Lillo, A.
    Guerrero, J.
    Cano, F.
    PEDIATRIC NEPHROLOGY, 2009, 24 (09) : 1877 - 1877
  • [49] Periodontal risk profiles of a thuringian population.
    Hoffmann, T
    Werneburg, K
    Wiedemann, B
    Denardin, E
    Grossi, S
    Dunford, B
    Genco, RJ
    JOURNAL OF DENTAL RESEARCH, 1997, 76 : 3162 - 3162
  • [50] Haplotype combination 11.21 in the promoter of the adiponectin gene (APM1) is associated with increased diabetes risk in Caucasian population.
    Schwarz, PEH
    Towers, W
    Görgens, H
    Fücker, K
    Schwanebeck, U
    Rietzsch, H
    Fischer, S
    Julius, U
    Schulze, J
    Olkers, A
    Schackert, HK
    DIABETOLOGIA, 2003, 46 : A137 - A137
12345